Stephen B. Soumerai, ScD

  • 4Articles
  • 14.5KReads
  • 2007–2022Active
  • 17Collaborators
  • 9Citations

About

Stephen B. Soumerai, ScD is affiliated with Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts. Stephen B. Soumerai has authored or co-authored 4 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2007 and 2022. Their work focuses on Bipolar Disorder, Depression (MDD), and Schizophrenia/Schizoaffective Disorders.

Publications

JCP
HSA-HDHPs and Bipolar Disorder Medication Cost Burden
Original Research

HSA-HDHPs and Bipolar Disorder Medication Cost Burden

March 9, 2022

This study examined the effects of high-deductible health plans paired with health savings accounts (HSA-HDHPs)—which require substantial out-of-pocket spending for most services—on medication out-of-pocket spending in people with bipolar...
, , , et al
JCP
Original Research

Gabapentin Lawsuit Among Patients with Bipolar

October 16, 2012

Read our full evaluation on the $430 million gabapentin off-label marketing lawsuit and how it affected patients diagnosed with bipolar disorder.
, , , et al
JCP
Original Research

A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia

January 15, 2008

, , , et al
JCP
Original Research

Provider and Patient Characteristics Associated With Antidepressant Nonadherence: The Impact of Provider Specialty

June 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe